98%
921
2 minutes
20
In recent years, some scholars from China have deeply discussed about the concept, connotation and calculating method of nitrogen use efficiency (NUE), and have raised questions and also put forward some improved methods for NUE calculation in cultivated lands. In this paper, we compared advantages and disadvantages of these improved NUE calculation methods by using the data from a 5-year positioning field experiment under a wheat-maize rotation system. The results indicated that it made mistakes when the traditional subtraction method was used to calculate NUE for wheat season and maize season separately, since the soil fertility level of experimental plots had differed significantly from each other after several seasons or years of different fertilization managements. Additionally, the calculated NUE increased markedly with the cropping season going, thus making it difficult to mirror the actual situation of N utilization in cultivated lands. For the wheat-maize rotation system, the cumulative NUE calculation method considered wheat season and maize season as a whole part, and skillfully avoided mistakes which could be caused by inhomogeneity of soil fertility levels between experimental plots. Moreover, the calculated NUE were comparably smaller, with smaller coefficient variations (CVs), in contrast with the traditional subtraction method. The NUE calculated by using the ratio method were bigger, with the smallest CVs, than that computed by using the cumulative calculation method. The soil N balance method took a thoughtful consideration about the budgets and losses of soil nutrients before and after crop growth, but obtained the largest values of NUE and CVs within these methods.
Download full-text PDF |
Source |
---|
Nutr Clin Pract
September 2025
Department of Clinical Nutrition, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Objective: The cachexia index (CXI) demonstrates potential as both a diagnostic tool for cachexia and a prognostic tool for survival in cancer. However, CXI's predictive value has not been verified in cervical cancer. The purpose of this study is to investigate the prognostic value of the CXI in patients with cervical cancer treated with radiotherapy.
View Article and Find Full Text PDFWounds
August 2025
Solventum, Maplewood, MN, USA.
Background: Initially limited to inpatient use, negative pressure wound therapy (NPWT) is now frequently used in community settings. However, complexities in wound management step-down strategies in the United Kingdom, including regional variations in referral processes, lack of consensus on funding criteria, and limited availability of NPWT units, have led to extended hospital length of stay (LOS) for patients ready for discharge but still needing NPWT. Single-use NPWT (sNPWT) can serve as a bridge between hospital and community NPWT.
View Article and Find Full Text PDFInfect Dis Ther
September 2025
School of Biomedical Sciences, The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
Introduction: The high mortality of Coronavirus Disease 2019 (COVID-19) highlights the need for safe and effective antiviral treatment. Small molecular antivirals (remdesivir, molnupiravir, nirmatrelvir/ritonavir) and immunomodulators (baricitinib, tocilizumab) have been developed or repurposed to suppress viral replication and ameliorate cytokine storms, respectively. Despite U.
View Article and Find Full Text PDFObes Surg
September 2025
Clinique Mutualiste de Pessac, Pessac, France.
Background: Preoperative treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) before bariatric surgery has not been studied. Therefore, we investigated the impact of neoadjuvant treatment with GLP-1 RAs on weight loss and postoperative outcomes in patients who underwent sleeve gastrectomy for severe obesity.
Method: A retrospective single-center study was conducted between January 2022 and December 2023.
Drug Saf
September 2025
School of Health Policy and Management, York University, 4700 Keele St., Toronto, ON, M3J 1P3, Canada.
Introduction: At times it is necessary to withdraw drugs after they have been approved because of lack of effectiveness or safety concerns. Health Canada does not keep a list of withdrawn drugs.
Objective: The aim of this study was to generate a list of all drugs approved since 1990 and subsequently withdrawn from the Canadian market for safety or effectiveness reasons until the end of 2024.